Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lung Diseases: early-phase trial registry
10 of 32 indexed Lung Diseases trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #477 of 28,707 conditions by registered trial count.
32 US clinical trials · 10 currently recruiting · #477 of 28,707 conditions by registered trial count
Lung Diseases: 32 US clinical trials tracked, 10 recruiting.
Lung Diseases is the subject of 32 registered US clinical trials on ClinicalTrials.gov, 10 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is Johns Hopkins University, running 3 of these trials.
Enrollment posture brief
Registry condition lung-diseases
OPEN 10 | RECR 31% | LATE 3 | EARLY 6 | RANK #477 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Aortic Valve Disease (31% recruiting · 16 trials)
Lung Diseases lists 10 open slots (31% of 32 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Lung Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Lung Diseases is recruiting below its size-band peers.
10 of 32 indexed trials (31.3%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Lung Diseases trials is spread across many organizations.
Johns Hopkins University accounts for 3 of 32 trials (9.4%). 26 distinct sponsors appear on at least one study for this condition label.
-
Typical Lung Diseases enrolment sits around 263 participants.
Median target enrolment is 263 among the 32 trials that report a genuine target (sentinel values excluded). 6 of those (18.8%) plan for fewer than 100 participants.
-
Lung Diseases splits between interventional and observational designs.
18 interventional and 14 observational studies make up this index (56.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
32 total, page 1 of 1
American Lung Association (ALA) Lung Health Cohort
Johns Hopkins University
NCT04543461
Real World Registry for Use of the Ion Endoluminal System
Intuitive Surgical
NCT06004440
Cough Capture as a Portal Into the Lung
Albert Einstein College of Medicine
NCT05854563
Deep Functional Phenotyping of the ALA Lung Health Cohort
Johns Hopkins University
NCT06177717
Housing, Environment, And Living Conditions for Transformed Health
University of Alabama at Birmingham
NCT06925373
Data Collection Using Eko Digital Devices in a Clinical Setting
Eko Devices
NCT07227376
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
University of Miami
NCT06494033
Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research
Baylor Research Institute
NCT04664192
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Dana-Farber Cancer Institute
NCT05922761
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Pulmovant
NCT07333183
Molecular Epidemiology of Acute Respiratory Distress Syndrome (ARDS)
Massachusetts General Hospital
NCT00006496
Data Collection For Adventitious Lung Sounds Algorithm Using Eko Digital Devices in a Clinical Setting
Eko Devices
NCT07360522
Gene Modifiers of Cystic Fibrosis Lung Disease
University of North Carolina, Chapel Hill
NCT00037765
Clinical Utility for Ion Endoluminal System
Intuitive Surgical
NCT03893539
A Study of Mosliciguat in PH-ILD
Pulmovant
NCT06635850
Aventus Thrombectomy System Pulmonary Embolism Clinical Study
Inquis Medical
NCT05907564
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
H. Lee Moffitt Cancer Center and Research Institute
NCT03598309
Prospective Investigation of Pulmonary Embolism Diagnosis III
George Washington University
NCT00241826
Apnea Positive Pressure Long-Term Efficacy Study
Stanford University
NCT00051363
Stress, Environment, and Genetics in Urban Children With Asthma
Brigham and Women's Hospital
NCT00269256
Prevalence of Sleep-Disordered Breathing in Children
Milton S. Hershey Medical Center
NCT00022789
A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.
Pfizer
NCT00808288
Study of Acid Reflux in Asthma
Johns Hopkins Bloomberg School of Public Health
NCT00069823
Effectiveness of Public Health Model of Latent Tuberculosis Infection Control for High-Risk Adolescents
San Diego State University
NCT00233168
Environmental Tobacco Smoke Exposure Reduction in High-Risk Preteens
San Diego State University
NCT00217893
Behavioral Interventions for Control of TB
Columbia University
NCT00005739
Influence of Data Collection Mode on Self-Report Validity of Asthma Therapy Adherence
Johns Hopkins University
NCT00233233
Randomized Controlled Trial of Exercise Training in Patients With COPD
US Department of Veterans Affairs
NCT00012792
Exhaled Carbon Monoxide (eCO) for Diffusing Capacity (DLCO) Correction
University of California, Los Angeles
NCT01126047
Asthma Data Innovation Demonstration Project
David Van Sickle
NCT02162576
Palliative Care Coaching for Families With Rare Advanced Lung Diseases
West Virginia University
NCT03813667
Combination Paclitaxel, Carboplatin and Temozolomide
New Mexico Cancer Research Alliance
NCT00249964
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 5 |
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Lung Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Lung Diseases trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Lung Diseases page
32 registered trials, 10 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 10 Lung Diseases trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Johns Hopkins University sponsors the most Lung Diseases trials on record, review their full trial history before evaluating a specific study. See Johns Hopkins University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lung Diseases condition card totals 32 registered trials; most-linked intervention Dry Powder Inhaler; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.